The UK has launched a £42 million program to screen men for prostate cancer and reduce deaths from the disease by up to 40 per cent.
According to what was published in The Times magazine, the Prostate Cancer Foundation was launched in England The Transform program, which is “a pivotal moment in the history of prostate cancer research,” aims to save thousands of lives in… United Kingdom Every year in addition to helping people avoid the harm caused by unnecessary biopsies and treatments.
12 thousand die each year from prostate cancer
More than 44,000 men are diagnosed with the disease every year England Prostate cancer, research is considered cancer In the United Kingdom, 12,000 people die from this condition each year.
The program’s screening aims to detect the disease even when symptoms do not appear, and TRANSFORM is the largest screening test Prostate cancer Two decades old, and currently the only trial, it was developed with the support of the NHS, the National Institute for Health and Care Research, and the government, which has pledged to contribute £16 million.
Health Minister Victoria Atkins said: “We hope this funding will help save the lives of thousands more men through advanced screening methods that detect prostate cancer as early as possible. “
The trial will compare different screening methods and diagnostic processes used in the NHS today, including blood tests, physical examinations and biopsies.
The first phase will involve around 12,500 men receiving prostate specific antigen (PSA) tests as well as genetic tests, and a faster version of the B imaging test.Magnetic ResonanceInitial results of the trial are expected to emerge within three years.
The program aims to reduce deaths by 40 percent
According to Prostate Cancer UK, which is funding the project, previous trials using PSA blood tests and biopsies to screen for the disease showed that the method prevented between 8 and 20 per cent of deaths, depending how regular the screening was.
However, the charity said Transform had the potential to reduce the number of deaths from prostate cancer by 40 per cent.
Dr Matthew Hobbs, director of research at the Prostate Cancer Centre, said: BritainProstate cancer is the most common type cancer “It’s common to not have a screening program, and it’s time to change that.”
He said: “We know that early diagnosis saves lives, but previous trials have not been able to prove that enough men could be saved using PSA tests alone, while they show that these older screening methods unnecessarily harmed men.”
Hobbs continued, “We now need to prove that there are better ways to detect aggressive prostate cancer that save more lives while doing less harm.”
Hamas is losing its supporters… and a promising drug for cancer
The second phase of the trial, involving up to 300,000 men, will test the most promising options from the first phase of the trial, and the team will follow patients for at least a decade after the trial to monitor how the screening affects their lives. .
The researchers are focusing on it Imperial College London, University College London, Queen Mary University of London and the Institute for Cancer Research aim to make the trial as accessible as possible by recruiting patients from general practice across the UK from next year.
Black men are more likely to get prostate cancer
One in ten men invited to the screening test will be black, as black men are twice as likely to get prostate cancer as men of other races.
Eligible participants will also be men between 50 and 75, and black men aged 45 to 75 can participate.
2024-05-01 09:48:19
#Britain..program #save #thousands #men #deadly #cancer
